Allplex™ HPV HR Detection

WHO recommends DNA testing for primary cervical cancer screening and the recent trends show that screening method is shifting from the cytology test to HPV DNA test. Furthermore, the prevalence of HPV type is different across the world due to increasing vaccination and difference in regional characteristics, leading DNA testing more useful in screening HPVs. Allplex™ HPV HR Detection is a multiplex real-time PCR assay that enables simultaneous amplification and detection of target nucleic acids of 12 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) and 66, 68 as well as Internal Control (IC)